Effects of target composition on the optical constants of DC sputtered ZnO: Al thin films

Al-doped ZnO thin films were deposited from ZnO:Al ceramic and Zn:Al metal alloy targets in Ar and Ar + O2 atmospheres respectively, using Direct Current (DC) magnetron sputtering. The samples exhibited transmittance T > 80% in visible region with good NIR shielding. The results indicated that, band gap energy ranged from 3.34 to 3.44 eV and 3.39 to 3.46 eV for films prepared from alloy and ceramic targets, respectively. Films obtained from alloy target at a substrate temperature of 200 oC showed low electrical sheet resistance of 10 Ω/sq, and highest values of mobility (15.9 cm2/Vs) and carrier concentration (2.98 × 1021 cm-3). However, films prepared from ceramic target at a substrate temperature of 300 oC revealed the highest sheet resistance of 32 Ω/sq, with lower values of mobility (14.1 cm2/Vs) and carrier concentration (1.92 × 1020 cm-3). The increase in sheet resistance and decrease in mobility as well as carrier concentration might be due to increased scattering centers for carriers, resulting to increased sheet resistance. Optical spectra of the films were fitted to SCOUT software in order to determine the refractive index, n and extinction coefficient, k. Generally, the calculated n and k in the visible part of the solar spectrum for different samples, ranged from 1.59 to 2.2 and 0.00013 to 0.0194 respectively, which are in agreement with results obtained using other methods. In general, the findings of this study shows that alloy target is suitable for deposition of ZnO:Althin films for devices/applications where low deposition temperature is required.Keywords: DC Magnetron Sputtering, Optical Constants, Transparent Conducting Oxides (TCO

Access to Water among Slum Dwellers in Nakuru Town, Kenya: Lessons from Kaptembwa Location

Majority of urban residents in sub-Saharan Africa live in slums often characterised by lack of basic services such as water and sewerage.  With increasing pressures due to population growth, aging infrastructure, climate change, coupled with an unsustainable conventional water management, cities and urban areas in sub-Saharan African countries are facing enormous difficulties and will experience huge challenges in future in efficiently managing the scarce and increasingly unreliable water resources. This paper examines the level of access to water among slum dwellers in Nakuru town, Kaptembwo location, Kenya. The guiding questions the paper addresses are: (1) What is the level of households’ access to water? and (2) Has NAWASSCO met the demand for water by residents? A descriptive survey design was used and structured questionnaire administered to 280 households to collect the requisite data. Data was analyzed using descriptive statistical techniques and statistical software (SPSS) version 20. Results show that only 65.6% of the basic water requirements of the residents are met and that only 25% of the households access the minimum recommended 50 l/c/d. The low levels of investment in water infrastructure is the major explanatory reason for reduced access to water services. The paper shows that the domestic water supply in Kaptembwo is quite low according to the international standards. This situation is attributed to poor and inefficient water distribution system, unreliable and irrational rationing system, and poor management of water delivery services by NAWASSCO. This paper thus recommends that NAWASSCO should improve its distribution network and related infrastructure in order to facilitate adequate and reliable water provision to the study area. Other strategies including roof-harvesting and collection of run-off water if properly planned and managed could increase the water supply situation in the study area. Keywords: Access, water services, water supply, slums, household, water infrastructur

XML navigation and transformation by tree-walking automata and transducers with visible and invisible pebbles

Algorithms and the Foundations of Software technolog

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

SummaryBackgroundWHO recommends combinations of an artemisinin derivative plus an antimalarial drug of longer half-life as treatment options for uncomplicated Plasmodium falciparum infection. In Africa, artemether–lumefantrine is the most widely used artemisinin-based combination therapy, whereas artesunate–mefloquine is used infrequently because of a perceived poor tolerance to mefloquine. WHO recommends reconsideration of the use of artesunate–mefloquine in Africa. We compared the efficacy and safety of fixed-dose artesunate–mefloquine with that of artemether–lumefantrine for treatment of children younger than 5 years with uncomplicated P falciparum malaria.MethodsWe did this multicentre, phase 4, open-label, non-inferiority trial in Burkina Faso, Kenya, and Tanzania. Children aged 6–59 months with uncomplicated malaria were randomly assigned (1:1), via a computer-generated randomisation list, to receive 3 days' treatment with either one or two artesunate–mefloquine tablets (25 mg artesunate and 55 mg mefloquine) once a day or one or two artemether–lumefantrine tablets (20 mg artemether and 120 mg lumefantrine) twice a day. Parasitological assessments were done independently by two microscopists who were blinded to treatment allocation. The primary outcome was the PCR-corrected rate of adequate clinical and parasitological response (ACPR) at day 63 in the per-protocol population. Non-inferiority was shown if the lower limit of the 95% CI for the difference between groups was greater than −5%. Early vomiting was monitored and neuropsychiatric status assessed regularly during follow-up. This study is registered with ISRCTN, number ISRCTN17472707, and the Pan African Clinical Trials Registry, number PACTR201202000278282.Findings945 children were enrolled and randomised, 473 to artesunate–mefloquine and 472 to artemether–lumefantrine. The per-protocol population consisted of 407 children in each group. The PCR-corrected ACPR rate at day 63 was 90·9% (370 patients) in the artesunate–mefloquine group and 89·7% (365 patients) in the artemether–lumefantrine group (treatment difference 1·23%, 95% CI −2·84% to 5·29%). At 72 h after the start of treatment, no child had detectable parasitaemia and less than 6% had fever, with a similar number in each group (21 in the artesunate–mefloquine group vs 24 in the artemether–lumefantrine group). The safety profiles of artesunate–mefloquine and artemether–lumefantrine were similar, with low rates of early vomiting (71 [15·3%] of 463 patients in the artesunate–mefloquine group vs 79 [16·8%] of 471 patients in the artemether–lumefantrine group in any of the three dosing days), few neurological adverse events (ten [2·1%] of 468 vs five [1·1%] of 465), and no detectable psychiatric adverse events.InterpretationArtesunate–mefloquine is effective and safe, and an important treatment option, for children younger than 5 years with uncomplicated P falciparum malaria in Africa.FundingAgence Française de Développement, France; Department for International Development, UK; Dutch Ministry of Foreign Affairs, Netherlands; European and Developing Countries Clinical Trials Partnership; Fondation Arpe, Switzerland; Médecins Sans Frontières; Swiss Agency for Development and Cooperation, Switzerland

Remanent Magnetic Measurements on Perpendicular Recording Materials with Compensation for Demagnetizing Fields

Existing techniques for characterization of longitudinal recording media using remanence measurements are extended to perpendicular media, in particular to Alumite, and correction for demagnetizing fields is taken into account. It is found that these techniques have limited value because of the sensitivity of the analysis to the correction factor used. Measurement of the recoil lines is investigated as an alternative method of probing the reversal processes

Vector competence of populations of Aedes aegypti from three distinct cities in Kenya for chikungunya virus

BACKGROUND : In April, 2004, chikungunya virus (CHIKV) re-emerged in Kenya and eventually spread to the islands in the Indian Ocean basin, South-East Asia, and the Americas. The virus, which is often associated with high levels of viremia in humans, is mostly transmitted by the urban vector, Aedes aegypti. The expansion of CHIKV presents a public health challenge both locally and internationally. In this study, we investigated the ability of Ae. aegypti mosquitoes from three distinct cities in Kenya; Mombasa (outbreak prone), Kisumu, and Nairobi (no documented outbreak) to transmit CHIKV. METHODOLOGY/PRINCIPAL FINDINGS : Aedes aegypti mosquito populations were exposed to different doses of CHIKV (105.6±7.5 plaque-forming units[PFU]/ml) in an infectious blood meal. Transmission was ascertained by collecting and testing saliva samples from individual mosquitoes at 5, 7, 9, and 14 days post exposure. Infection and dissemination were estimated by testing body and legs, respectively, for individual mosquitoes at selected days post exposure. Tissue culture assays were used to determine the presence of infectious viral particles in the body, leg, and saliva samples. The number of days post exposure had no effect on infection, dissemination, or transmission rates, but these rates increased with an increase in exposure dose in all three populations. Although the rates were highest in Ae. aegypti from Mombasa at titers 106.9 PFU/ml, the differences observed were not statistically significant (χ2 1.04, DF = 1, P 0.31). Overall, about 71% of the infected mosquitoes developed a disseminated infection, of which 21% successfully transmitted the virus into a capillary tube, giving an estimated transmission rate of about 10% for mosquitoes that ingested 106.9 PFU/ml of CHIKV. All three populations of Ae. aegypti were infectious as early as 5±7 days post exposure. On average, viral dissemination only occurred when body titers were 104 PFU/ ml in all populations. CONCLUSIONS/SIGNIFICANCE : Populations of Ae. aegypti from Mombasa, Nairobi, and Kisumu were all competent laboratory vectors of CHIKV. Viremia of the infectious blood meal was an important factor in Ae. aegypti susceptibility and transmission of CHIKV. In addition to viremia levels, temperature and feeding behavior of Ae. aegypti may also contribute to the observed disease patterns.The National Institutes of Health (NIH), Grant No. 1R01AI099736-01A1 to RS, UK's Department for International Development (DFID), Swedish International Development Cooperation Agency (Sida), the Swiss Agency for Development and Cooperation (SDC) and the Kenyan Government.http://www.plosntds.orgam2017Medical Virolog

Prevalence of enteropathogenic viruses and molecular characterization of group A rotavirus among children with diarrhea in Dar es Salaam Tanzania

Different groups of viruses have been shown to be responsible for acute diarrhea among children during their first few years of life. Epidemiological knowledge of viral agents is critical for the development of effective preventive measures, including vaccines. In this study we determined the prevalence of the four major enteropathogenic viruses - rotavirus, norovirus, adenovirus and astrovirus - was determined in 270 stool samples collected from children aged 0 - 60 months who were admitted with diarrhea in four hospitals in Dar es Salaam, Tanzania, using commercially available ELISA kits. In addition, the molecular epidemiology of group A rotavirus was investigated using reverse transcriptase multiplex polymerase chain reaction (RT-PCR). At least one viral agent was detected in 87/270 (32.2%) of the children. The prevalence of rotavirus, norovirus, adenovirus and astrovirus was 18.1%, 13.7%, 2.6% and 0.4%, respectively. In most cases (62.1%) of viruses were detected in children aged 7-12 months. The G and P types (VP7 and VP4 genotypes respectively) were further investigated in 49 rotavirus ELISA positive samples. G9 was the predominant G type (81.6%), followed by G1 (10.2%) and G3 (0.2%). P[8] was the predominant P type (83.7%), followed by P[6] (0.4%) and P[4] (0.2%). The following G and P types were not detected in this study population; G2, G4, G8 G10, P[9], P[10] and P[11]. The dominating G/P combination was G9P[8], accounting for 39 (90.7%) of the 43 fully characterized strains. Three (6.1%) of the 49 rotavirus strains could not be typed. Nearly one third of children with diarrhea admitted to hospitals in Dar es Salaam had one of the four viral agents. The predominance of rotavirus serotype G9 may have implication for rotavirus vaccination in Tanzania

IgG Responses to Anopheles gambiae Salivary Antigen gSG6 Detect Variation in Exposure to Malaria Vectors and Disease Risk

Assessment of exposure to malaria vectors is important to our understanding of spatial and temporal variations in disease transmission and facilitates the targeting and evaluation of control efforts. Recently, an immunogenic Anopheles gambiae salivary protein (gSG6) was identified and proposed as the basis of an immuno-assay determining exposure to Afrotropical malaria vectors. In the present study, IgG responses to gSG6 and 6 malaria antigens (CSP, AMA-1, MSP-1, MSP-3, GLURP R1, and GLURP R2) were compared to Anopheles exposure and malaria incidence in a cohort of children from Korogwe district, Tanzania, an area of moderate and heterogeneous malaria transmission. Anti-gSG6 responses above the threshold for seropositivity were detected in 15% (96/636) of the children, and were positively associated with geographical variations in Anopheles exposure (OR 1.25, CI 1.01–1.54, p = 0.04). Additionally, IgG responses to gSG6 in individual children showed a strong positive association with household level mosquito exposure. IgG levels for all antigens except AMA-1 were associated with the frequency of malaria episodes following sampling. gSG6 seropositivity was strongly positively associated with subsequent malaria incidence (test for trend p = 0.004), comparable to malaria antigens MSP-1 and GLURP R2. Our results show that the gSG6 assay is sensitive to micro-epidemiological variations in exposure to Anopheles mosquitoes, and provides a correlate of malaria risk that is unrelated to immune protection. While the technique requires further evaluation in a range of malaria endemic settings, our findings suggest that the gSG6 assay may have a role in the evaluation and planning of targeted and preventative anti-malaria interventions

Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa

Recent developments in molecular biology and genomics have revolutionized biology and medicine mainly in the developed world. The application of next generation sequencing (NGS) and CRISPR-Cas tools is now poised to support endemic countries in the detection, monitoring and control of endemic diseases and future epidemics, as well as with emerging and re-emerging pathogens. Most low and middle income countries (LMICs) with the highest burden of infectious diseases still largely lack the capacity to generate and perform bioinformatic analysis of genomic data. These countries have also not deployed tools based on CRISPR-Cas technologies. For LMICs including Tanzania, it is critical to focus not only on the process of generation and analysis of data generated using such tools, but also on the utilization of the findings for policy and decision making. Here we discuss the promise and challenges of NGS and CRISPR-Cas in the context of malaria as Africa moves towards malaria elimination. These innovative tools are urgently needed to strengthen the current diagnostic and surveillance systems. We discuss ongoing efforts to deploy these tools for malaria detection and molecular surveillance highlighting potential opportunities presented by these innovative technologies as well as challenges in adopting them. Their deployment will also offer an opportunity to broadly build in-country capacity in pathogen genomics and bioinformatics, and to effectively engage with multiple stakeholders as well as policy makers, overcoming current workforce and infrastructure challenges. Overall, these ongoing initiatives will build the malaria molecular surveillance capacity of African researchers and their institutions, and allow them to generate genomics data and perform bioinformatics analysis in-country in order to provide critical information that will be used for real-time policy and decision-making to support malaria elimination on the continent